Guizhou Chitianhua Co., Ltd. Class A

Guizhou Chitianhua Co., Ltd., established in Guiyang, China, in 1998, operates as a diversified enterprise primarily focused on the chemical and pharmaceutical sectors. Its chemical division manufactures and distributes a range of products including urea fertilizers, synthetic ammonia, ammonium sulfate, sulfuric acid, and industrial gases such as nitrogen, ammonia, and hydrogen, alongside other fundamental chemical products and their derivatives. In its pharmaceutical segment, the company develops and markets a broad portfolio of medications addressing conditions like diabetes, cardiovascular diseases, dermatological issues, gynecological problems, digestive system disorders, endocrine imbalances, and psychiatric ailments. This area also encompasses medical equipment, traditional Chinese and Western patented medicines, Class II clinical laboratory analysis instruments, and hygiene products. Beyond these core operations, Guizhou Chitianhua engages in an extensive array of ancillary businesses. These activities include the production and sale of specialized and everyday chemical goods; providing technical development, consulting, and technology transfer services; coal washing and sales; import and export of goods and technology; vehicle repair; and the sale of health care products and prepackaged foods. The company also offers software development, data processing, health consultation, cosmetic manufacturing, cultivation of Chinese herbal medicines, cell storage, advanced research in stem cell biotechnology and gene technology, and the production of biological products. Furthermore, it invests in coal construction projects and trades industrial and mining products, equipment, and spare parts. The company officially adopted its current name, Guizhou Chitianhua Co., Ltd., in May 2023, having previously been known as Guizhou Salvage Pharmaceutical Co.,Ltd.

Guizhou Chitianhua Co., Ltd. Class A trades as 600227.SS on SHH. The company is classified in Basic Materials / Agricultural Inputs and reports in CNY.

The current profile places the business in Agricultural Inputs. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Guizhou Chitianhua Co., Ltd. Class A can be compared against peers such as Grand Industrial Holding Co., Ltd., Sichuan Meifeng Chemical Industry Co., Ltd., Jiangsu Changqing Agrochemical Co., Ltd., Jiangsu Flag Chemical Industry Co., Ltd., Anhui Liuguo Chemical Co., Ltd., Shandong Lubei Chemical Co., Ltd..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $4.76B, beta of 0.01, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

600227.SS currently shows total debt of N/A and beta of 0.01. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.gzsjt.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.